Holen Sie sich die Stockscreener-App
23.00
2.42%
-0.57
Celldex Therapeutics Inc Aktie (CLDX) Neueste Nachrichten
Will Celldex Therapeutics Inc. benefit from geopolitical trends2025 Volume Leaders & High Accuracy Investment Signals - mfd.ru
Celldex Therapeutics Teases Key Barzolvolimab Phase 3 Updates, New Data at Guggenheim Summit - MarketBeat
Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a 115% Potential Upside in the Biotech Arena - DirectorsTalk Interviews
(02/11/26) Top Picks 2026: Celldex Therapeutics Inc. (CLDX) - moneyshow.com
Can Celldex Therapeutics Inc. disrupt its industryGlobal Markets & AI Driven Stock Reports - mfd.ru
Biotech Celldex to field investor questions at 3 conferences - Stock Titan
Celldex to Present at Upcoming Investor Conferences - Yahoo Finance
Celldex Therapeutics Breaks Below 200-Day Moving AverageNotable for CLDX - Nasdaq
Assessing Celldex Therapeutics (CLDX) Valuation After Recent Share Price Momentum And Ongoing Losses - Sahm
Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Exploring a Potential 116% Upside in Biotech Innovation - DirectorsTalk Interviews
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Celldex’s EvolvE Study Completion Sets Up Key Catalyst in Eosinophilic Esophagitis - TipRanks
Whats Radiant Logistics Incs historical returnQuarterly Market Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Update Recap: Does Celldex Therapeutics Inc stock benefit from AI growthMarket Rally & AI Powered Market Entry Strategies - baoquankhu1.vn
A Look At Celldex Therapeutics (CLDX) Valuation After Recent Weak Trading Performance - Yahoo Finance
Is Celldex Therapeutics (CLDX) Pricing Reflect Its DCF Upside After Mixed Multi‑Year Returns - Sahm
Will Celldex Therapeutics Inc. benefit from government policyJuly 2025 Summary & Stepwise Trade Signal Guides - mfd.ru
Celldex Therapeutics (CLDX) Investor Outlook: Analysts See Over 100% Upside Potential - DirectorsTalk Interviews
Growth Report: Will Celldex Therapeutics Inc benefit from geopolitical trends2025 Pullback Review & Consistent Income Trade Recommendations - baoquankhu1.vn
A Look At Celldex Therapeutics (CLDX) Valuation After Recent Share Price Weakness - Sahm
Will Celldex Therapeutics Inc. stock hit new highs in YEARWeekly Stock Recap & Pattern Based Trade Signal System - mfd.ru
Day Trade: cờ tướng họcEarnings Growth Summary & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Sees Large Growth in Short Interest - MarketBeat
Pullback Watch: Whats the fair value of Celldex Therapeutics Inc stockWeekly Trend Report & Long-Term Growth Plans - baoquankhu1.vn
Reassessing Celldex Therapeutics (CLDX) Valuation As Shares Trade At A Discount To DCF Estimates - Sahm
Value Recap: Is Celldex Therapeutics Inc stock resilient to inflationFed Meeting & Smart Allocation Stock Tips - Bộ Nội Vụ
Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Unpacking a 107.86% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Celldex Therapeutics SVPs Engage In Heavy Transactions - AOL.com
Celldex Therapeutics (NASDAQ:CLDX) Trading Down 7.5%Here's Why - MarketBeat
Market Pulse: Can Celldex Therapeutics Inc disrupt its industryMarket Rally & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Can Celldex Therapeutics Inc disrupt its industry2025 Geopolitical Influence & Reliable Price Action Trade Plans - baoquankhu1.vn
How Advancing Antibody Pipeline And 2027 Cash Runway At Celldex Therapeutics (CLDX) Has Changed Its Investment Story - Sahm
Will Celldex Therapeutics Inc. stock see insider buyingPortfolio Risk Summary & Detailed Earnings Play Strategies - ulpravda.ru
Will Celldex Therapeutics Inc. stock deliver better than expected guidanceQuarterly Profit Report & Advanced Swing Trade Entry Plans - Улправда
Why Celldex Therapeutics Inc. (TCE2) stock could be top winnerJuly 2025 Chart Watch & Fast Entry High Yield Tips - Улправда
Is Celldex Therapeutics (CLDX) Pricing Reflect Its DCF Upside After Recent Share Swings - Sahm
Will Celldex Therapeutics Inc. stock attract more institutional investors2025 Market Overview & Precise Swing Trade Alerts - Улправда
Can Celldex Therapeutics Inc. stock deliver surprise earnings beatStop Loss & Daily Growth Stock Investment Tips - Улправда
How Celldex Therapeutics Inc. stock trades during market volatility2025 Analyst Calls & Fast Entry Momentum Trade Alerts - Улправда
Is Celldex Therapeutics Inc. stock a good choice for value investorsMarket Sentiment Summary & Smart Allocation Stock Reports - Улправда
Chronic Spontaneous Urticaria Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Allakos, AstraZeneca, Biosana, Celldex Therapeutics, Celltrion, Eli Lilly and Company - Barchart.com
Celldex Therapeutics Builds Momentum Around Barzolvolimab And Bispecific Antibody Programs - RTTNews
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Celldex Therapeutics (CLDX) Stock Analysis: Biotechnology Innovator with Over 100% Upside Potential - DirectorsTalk Interviews
Celldex stock rating reiterated as Overweight by Cantor Fitzgerald - Investing.com Canada
Celldex Therapeutics (NASDAQ:CLDX) Trading 4.1% HigherShould You Buy? - MarketBeat
Simplify Asset Management Inc. Invests $2.20 Million in Celldex Therapeutics, Inc. $CLDX - MarketBeat
Short Interest in Celldex Therapeutics, Inc. (NASDAQ:CLDX) Declines By 20.9% - MarketBeat
Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Celldex Therapeutics, Inc. (CLDX) Stock Analysis: Strong Buy Ratings and Nearly 96% Upside Potential - DirectorsTalk Interviews
Barclays Lifts PT on Celldex Therapeutics (CLDX) to $24 From $21 - Insider Monkey
We're Hopeful That Celldex Therapeutics (NASDAQ:CLDX) Will Use Its Cash Wisely - Yahoo Finance
Corient Private Wealth LLC Purchases Shares of 201,717 Celldex Therapeutics, Inc. $CLDX - MarketBeat
12 Small Cap Stocks to Buy with Huge Upside Potential - Insider Monkey
Celldex Therapeutics (CLDX): Assessing Valuation After a Recent Share Price Uptick - Sahm
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):